News
Why Gilead Sciences Might Not Make an Oncology Acquisition
Is Gilead Sciences (NASDAQ: GILD) backing away from its plans to acquire a smaller biotech focusing on oncology? That could be the case. Gilead CEO John Milligan reportedly told Leerink analyst
The Hidden Gem in Novavax's Pipeline You'll Want to Watch
If you've looked into Novavax (NASDAQ: NVAX), you know the clinical-stage biotech's primary focus is on its experimental RSV F vaccine. Novavax has had its fair share of ups and downs with that
Why I Love Celgene Corporation
Stocks aren't like children. It's not a problem at all if you don't love each stock in your investment portfolio equally. You can have favorites without even the smallest amount of guilt.In my case
3 Stocks That Could Make You Rich
Railroads. Automobiles. Personal computers. The internet.What do all these things have in common? They're all examples of innovations from the past that have created huge new industries -- and made
3 Stocks to Buy With Dividends Yielding More Than 3%
Dividend stocks offer both income and long-term growth prospects. Smart dividend investors focus on the stocks that have the best chances of giving them both, maximizing their returns. Among
Novo Nordisk A/S Continues Its Comeback
Novo Nordisk (NYSE: NVO) released earnings for the first half of 2017, and while revenue growth wasn't spectacular, considering how last year went for the diabetes specialist, investors will take it.M
Alnylam Pharmaceuticals, Inc. Earnings: Waiting for Apollo
Alnylam Pharmaceuticals (NASDAQ: ALNY) reported second-quarter earnings last week -- and for the record, the company lost $118.4 million -- but without any products on the market, the focus of the
Here's My Top Stock to Buy in August
Last year, Bank of America/Merrill Lynch released their analysis of an interesting study that examined the performance of growth stocks versus value stocks over the 90-year period from 1926 to 2016
3 Beaten-Up Biotech Stocks: Are They Bargains?
The iShares Nasdaq Biotechnology Index has tacked on a healthy gain of around 15% so far this year, without any help from Celldex Therapeutics, Inc. (NASDAQ: CLDX), Agenus Inc. (NASDAQ: AGEN), or
This Struggling Marijuana Stock Finally Launched Its Highly Anticipated Drug
If you look around, chances are you won't find many marijuana stocks struggling. In fact, over the trailing one-year period, 12 out of 13 pot stocks with a market cap above $200 million had risen
Why Has 2017 Been a Horrible Year So Far for Biotech Acquisitions?
How many big biotech acquisitions can you name that have occurred so far in 2017?Johnson & Johnson (NYSE: JNJ) spent $30 billion to buy Swiss biotech Actelion. That's one. Then there's... well
This Technology Could Make You Rich -- and Change the World As We Know It
Revolutionary, game-changing, groundbreaking.These words are probably used too often in describing new innovations. The reality is that most new products and technologies don't live up to the hype
3 Marijuana Stocks That Could Make You the Most Money in the 2nd Half of 2017
For investors who enjoyed the huge run of marijuana stocks last year, the first half of 2017 probably hasn't been as exciting. Several of the largest marijuana stocks haven't performed all that great
Ionis Pharmaceuticals Inc: Growing Royalties, an Advancing Pipeline, and Getting Back Rights to Some Drugs
Ionis Pharmaceuticals (NASDAQ: IONS) reported second-quarter earnings earlier this week and then followed up on Friday with a disclosure that it's getting full rights back to two of its drugs
Intrexon Depended on 1 Customer for 58% of First-Half 2017 Revenue Growth
The single biggest problem facing engineered biology conglomerate Intrexon (NYSE: XON) heading into the second quarter of 2017 was its dependency on small- and micro-cap companies for a significant
2 Marijuana Stocks That Turned $10,000 Into $125,000 and $300,000, Respectively
When it comes to top-performing industries, you'd have a tough time surpassing the returns of marijuana stocks. Of the 13 marijuana stocks with a market cap in excess of $200 million, over half have
Better Buy: Exact Sciences Corporation vs. Opko Health
"It was the best of times, it was the worst of times..."Charles Dickens wasn't referring to Exact Sciences (NASDAQ: EXAS) and Opko Health (NASDAQ: OPK) when he wrote those words, but they're certainly
Why Impax Laboratories Inc Is Up for a Second Straight Day
Impax Laboratories (NASDAQ: IPXL) closed up 10% on Thursday after jumping 9.6% yesterday following its second-quarter earnings report. Today's move seems to be a continuation of yesterday's jump
Why Pan American Silver, Chefs' Warehouse, and Perrigo Jumped Today
Thursday was one of the worst sessions that the stock market has seen in several months, with major benchmarks falling 1% or more. Investors are growing increasingly nervous about the rising tensions
Here's Why Perrigo Company Rose as Much as 20.5% Today
Shares of Perrigo Company (NYSE: PRGO) rose over 20% this morning after the healthcare leader released second-quarter 2017 financial results and adjusted full-year 2017 guidance. While revenue slipped
3 High-Yield Healthcare Stocks
The healthcare sector is a natural hunting ground for income investors, since consumers demand access to high-quality healthcare products in good times and bad. That fact helps keep many healthcare
5 Reasons Valeant's Situation Could Get Worse
Valeant Pharmaceuticals (NYSE: VRX) announced some good news in its second-quarter update on Tuesday. The drugmaker now expects to cut its debt by $5 billion sooner than its previous target of
Organovo Holdings Revenue Is Growing at a Snail's Pace Compared With Prior Quarters
It's been a crazy year for Organovo Holdings (NASDAQ: ONVO) so far. The 3D bioprinting company's former CEO abruptly left in April. Organovo disappointed investors with its fourth-quarter and
Earnings Hangover Sacks Valeant Pharmaceuticals' Stock, Sending Shares Down 10%
Shares of embattled drugmaker Valeant Pharmaceuticals (NYSE: VRX) are pulling an about-face after initially moving higher following the release of its second-quarter earnings results before the
Why Red Robin Gourmet Burgers, Hertz Global Holdings, and Novo Nordisk Jumped Today
The stock market fell again on Wednesday, posting what has become an increasingly rare two-day losing streak. Major benchmarks gave up modest amounts of ground in the wake of some disappointing